glp 1 drugs heart failure The effect of GLP-1 receptor agonists on cardiac remodeling in patients with preserved and reduced ejection fraction: a systematic review and meta-analysis | Heart Failure Reviews How are GLP-1 drugs reshaping
Description
Nat Cancer 7 , 260271 (2026)
At trial completion, the primary outcome occurred in 108 patients (6.6%) in the semaglutide group versus 146 patients (8.9%) in the placebo group (hazard ratio [HR]: 0.74
10 Future perspectives In the recent era advancements seen in application of GLP-1RA is extensively appreciated to battle obesity and metabolic syndrome along with associated cardiovascular risks
GLP-1 receptor agonist medications slow gastric emptying, which further contributes to a feeling of satiety and reduces oral intake
Several GLP-1 medications are now available, each with different profiles
